| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |